Derniers essais

EudraCT Number: 2004-001653-28

Sponsor Protocol Number: 03/314

Start Date:

Sponsor Name: The Leeds teaching Hospitals NHS trust

Full Title: A comparison of the effects on prostaglandin synthesis and cytokine production of an olive-oil based lipid emulsion (Clinoloeic) with a soya based emulsion (Intralipid) in newborn infnats receiving...

Medical condition: Prematurity Parenteral nutrition

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Preterm newborn infants, Newborns, Under 18

Gender: Male, Female

Trial protocol: GB (GB - no longer in EU/EEA)

Trial results: (No results available)

EudraCT Number: 2009-009278-29

Sponsor Protocol Number: S51477

Start Date:

Sponsor Name: UZ Leuven

Full Title: Follow-up studie: Metformin therapie bij kinderen en adolescenten met neurogene of neuromusculaire aandoeningen

Medical condition: Neuromuscular and neurological diseases, associated with obesity and insulin resistance

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10022489	Insulin resistance	LLT
	9.1		10022489	Insulin resistance	PT
	9.1		10029883	Obesity	LLT
	9.1		10065941	Central obesity	PT

Population Age: Adolescents, Under 18

Gender: Male, Female

Trial protocol: BE (Ongoing)

Trial results: (No results available)

EudraCT Number: 2009-013956-62

Sponsor Protocol Number: DEMIJO

Start Date:

Sponsor Name: University Medical Center of the University Ulm

Full Title: Preparation of Neuroplant® 300mg N in film-coated tablets (St. John´s wort, SJW) in the treatment of mild to moderate Major Depressive Disorder (MDD) in adolescents from 12 to 17 years (inclusive):...

Medical condition: Mild to moderate MDD acc. DSM-IV-TR in adolescents (12−17years inclusive)

Disease:	Version	SOC Term	Classification Code	Term	Level
	12.0		10025453	Major depressive disorder NOS	LLT

Population Age: Adolescents, Under 18

Gender: Male, Female

Trial protocol: DE (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2009-013499-29

Sponsor Protocol Number: SUNDRO20

Start Date:

Sponsor Name: Technische Universität München

Full Title: Dosisfindungsstudie für Sugammadex und Neostigmin zur Reversierung einer geringen neuromuskulären Restblockade (train of four ratio 0,2) [Sugammadex and Neostigmine dose finding study for reversal ...

Medical condition: Dose finding study for sugammadex and/or neostigmine at residual neuromuscular blockade (whereas residual neuromuscular blockade is defined as a TOF of 0.2 in this study).

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10057286	Neuromuscular blockade reversal	LLT
	9.1		10057286	Neuromuscular blockade reversal	PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: DE (Completed)

Trial results: View results

EudraCT Number: 2013-001145-14

Sponsor Protocol Number: 2012.779

Start Date:

Sponsor Name: Hospices Civils de Lyon

Full Title: Traitement endoscopique de l’œsophage hypercontractile par injection de toxine botulinique : étude prospective, randomisée, contrôlée en double aveugle

Medical condition: Œsophage hypercontractile

Disease:	Version	SOC Term	Classification Code	Term	Level
	18.0	100000004856	10065279	Nutcracker oesophagus	LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2019-002161-36

Sponsor Protocol Number: OP-108

Start Date:

Sponsor Name: Oncopeptides AB

Full Title: A Randomized, Controlled, Open-Label Phase 3 Study of Melflufen in combination with Daratumumab Compared with Daratumumab in Patients with Relapsed or Relapsed-Refractory Multiple Myeloma

Medical condition: Patients with relapsed or relapsed-refractory multiple myeloma.

Disease:	Version	SOC Term	Classification Code	Term	Level
	16.1	100000004851	10028229	Multiple myelomas	HLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Prematurely Ended) NO (Completed) HU (Completed) FI (Completed) SK (Prematurely Ended) BG (Prematurely Ended) PL (Prematurely Ended) GR (Prematurely Ended) ES (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2011-005029-31

Sponsor Protocol Number: P110102

Start Date:

Sponsor Name: ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)

Full Title:

Medical condition:

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10038738 - Respiratory, thoracic and mediastinal disorders	10038683	Respiratory disorder	PT

Population Age: Children, Under 18

Gender:

Trial protocol: FR (Completed)

Trial results: (No results available)

EudraCT Number: 2009-014391-22

Sponsor Protocol Number: CCBC134A2404

Start Date:

Sponsor Name: Novartis Pharma AG

Full Title: An open label, multi-center, randomized, comparative Phase IIIb study to compare efficacy and safety of intravenous (i.v.) daptomycin with that of Semi-synthetic Penicillins (SSPs) or vancomycin in...

Medical condition: complicated skin and soft tissue infections.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Elderly

Gender: Male, Female

Trial protocol: DE (Completed) IT (Completed) ES (Completed) AT (Completed)

Trial results: View results

EudraCT Number: 2011-003784-30

Sponsor Protocol Number: CHUBX2011/20

Start Date:

Sponsor Name: CHU de bordeaux

Full Title: Rubinstein-Taybi syndrome: approach to functional imaging and therapeutic trial

Medical condition: Rubinstein-Taybi Syndrome

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10010331 - Congenital, familial and genetic disorders	10039281	Rubinstein-Taybi syndrome	PT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: FR (Ongoing)

Trial results: (No results available)

EudraCT Number: 2006-006204-11

Sponsor Protocol Number: 6096A1-3000

Start Date:

Sponsor Name: Wyeth Research Division of Wyeth Pharmaceuticals Inc.

Full Title: A Phase 3, Randomized, Active-Controlled, Double-Blind Trial Evaluating the Safety, Tolerability, and Immunogenicity of Manufacturing Scale 13-valent Pneumococcal Conjugate Vaccine

Medical condition: Healthy infants

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Infants and toddlers, Under 18

Gender: Male, Female

Trial protocol: PL (Ongoing)

Trial results: (No results available)

Derniers essais

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue